Logo     Print Page  Close Window


SEC Filings


S-3
FIBROCELL SCIENCE, INC. filed this Form S-3 on 01/18/2019
Entire Document
 


The Offering
 

Shares of common stock offered by the selling stockholders:
 
443,350 shares of common stock
 
 
 
Shares outstanding as of January 18, 2019
 
9,758,332
 
 
 
Terms of this offering:
 
The selling stockholders, including their transferees, donees, pledgees, assignees and successors-in-interest, may sell, transfer or otherwise dispose of any or all of the shares of common stock offered by this prospectus from time to time on the Nasdaq Capital Market or any other stock exchange, market or trading facility on which the shares are traded or in private transactions. The shares of common stock may be sold at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market price or at negotiated prices.

 
 
 
Use of proceeds:
 
All proceeds from the sale of shares of common stock offered hereby will be for the account of the selling stockholders. We will not receive any proceeds from the sale of common stock offered pursuant to this prospectus. See the caption “Use of Proceeds” in this prospectus.
 
 
 
Nasdaq Capital Market symbol:
 
FCSC
 
 
 
Trading:
 
Our shares of common stock currently trade on the Nasdaq Capital Market.
 
 
 
Risk factors:
 
Investing in our securities involves a high degree of risk and purchasers of our securities may lose their entire investment. See the information under the caption “Risk Factors” beginning on page 6 of this prospectus and the other information included elsewhere in this prospectus and incorporated by reference herein for a discussion of factors you should consider before deciding to invest in our securities.
 


5